NRX Pharmaceuticals (NRXP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.60, -4.06% vs the prior close of $2.71.
- Volume 1.21M shares, 1.4x its 50-day average.
- New SEC filings: 8-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
NRXP slides 4.1% to $2.60. Closed at $2.60, -4.06% vs the prior close of $2.71. Day range $2.57–$2.76, opened at $2.70.
NRXP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NRXP slides 4.1% to $2.60
- Closed at $2.60, -4.06% vs the prior close of $2.71. Day range $2.57–$2.76, opened at $2.70.
- Volume was 1.21M shares, 1.4x its 50-day average of 837.33K.
- Price is -19.4% vs its 50-day average ($3.23) and -12.1% vs its 200-day average ($2.96).
- 52-week range $1.62–$5.05; today's close sits at 29% of that range, 48.6% below the 52-week high.
Oct 15, 2026 — NRXP jumps 4.6% to $2.71
- Closed at $2.71, +4.63% vs the prior close of $2.59. Day range $2.48–$2.77, opened at $2.53.
- Volume was 1.18M shares, 1.4x its 50-day average of 827.50K.
- Price is -16.3% vs its 50-day average ($3.24) and -8.4% vs its 200-day average ($2.96).
- 52-week range $1.62–$5.05; today's close sits at 32% of that range, 46.4% below the 52-week high.
Oct 14, 2026 — NRXP slides 4.1% to $2.59, a 3-month low, 6 down days in a row
- Closed at $2.59, -4.07% vs the prior close of $2.70. Day range $2.56–$2.70, opened at $2.64.
- Volume was 695.80K shares, 0.8x its 50-day average of 838.71K.
- Price is -20.2% vs its 50-day average ($3.24) and -12.4% vs its 200-day average ($2.96).
- 52-week range $1.62–$5.05; today's close sits at 28% of that range, 48.8% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — NRXP slides 5.3% to $2.70, a 3-month low, 5 down days in a row
- Closed at $2.70, -5.26% vs the prior close of $2.85. Day range $2.67–$2.85, opened at $2.85.
- Volume was 552.50K shares, 0.7x its 50-day average of 840.01K.
- Price is -17.0% vs its 50-day average ($3.25) and -8.7% vs its 200-day average ($2.96).
- 52-week range $1.62–$5.05; today's close sits at 31% of that range, 46.6% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — NRXP ends flat (+0.0%) to $2.85, 4 down days in a row
- Closed at $2.85, +0.00% vs the prior close of $2.85. Day range $2.82–$2.93, opened at $2.85.
- Volume was 479.10K shares, 0.6x its 50-day average of 853.38K — lighter than usual.
- Price is -12.7% vs its 50-day average ($3.26) and -3.6% vs its 200-day average ($2.96).
- 52-week range $1.62–$5.05; today's close sits at 36% of that range, 43.6% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — NRXP dips 1.4% to $2.85, 3 down days in a row
- Closed at $2.85, -1.38% vs the prior close of $2.89. Day range $2.82–$2.89, opened at $2.89.
- Volume was 289.30K shares, 0.3x its 50-day average of 886.58K — lighter than usual.
- Price is -12.8% vs its 50-day average ($3.27) and -3.5% vs its 200-day average ($2.95).
- 52-week range $1.62–$5.05; today's close sits at 36% of that range, 43.6% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — NRXP dips 0.3% to $2.89
- Closed at $2.89, -0.34% vs the prior close of $2.90. Day range $2.81–$2.89, opened at $2.88.
- Volume was 645.60K shares, 0.7x its 50-day average of 889.26K.
- Price is -11.8% vs its 50-day average ($3.28) and -2.1% vs its 200-day average ($2.95).
- 52-week range $1.62–$5.05; today's close sits at 37% of that range, 42.8% below the 52-week high.
Oct 7, 2026 — NRXP dips 1.4% to $2.90
- Closed at $2.90, -1.36% vs the prior close of $2.94. Day range $2.87–$2.93, opened at $2.88.
- Volume was 404.70K shares, 0.4x its 50-day average of 901.94K — lighter than usual.
- Price is -11.6% vs its 50-day average ($3.28) and -1.7% vs its 200-day average ($2.95).
- 52-week range $1.62–$5.05; today's close sits at 37% of that range, 42.6% below the 52-week high.
Oct 6, 2026 — NRXP rises 2.4% to $2.94
- Closed at $2.94, +2.44% vs the prior close of $2.87. Day range $2.83–$2.97, opened at $2.89.
- Volume was 418.10K shares, 0.5x its 50-day average of 912.76K — lighter than usual.
- Price is -10.8% vs its 50-day average ($3.30) and -0.2% vs its 200-day average ($2.95).
- 52-week range $1.62–$5.05; today's close sits at 38% of that range, 41.8% below the 52-week high.
Oct 5, 2026 — NRXP dips 1.2% to $2.87
- Closed at $2.87, -1.20% vs the prior close of $2.90. Day range $2.79–$2.93, opened at $2.91.
- Volume was 675.20K shares, 0.7x its 50-day average of 915.09K.
- Price is -13.3% vs its 50-day average ($3.31) and -2.5% vs its 200-day average ($2.94).
- 52-week range $1.62–$5.05; today's close sits at 36% of that range, 43.2% below the 52-week high.
- SEC filings that day: 8-K.
Oct 2, 2026 — NRXP rises 1.9% to $2.90
- Closed at $2.90, +1.93% vs the prior close of $2.85. Day range $2.82–$2.94, opened at $2.91.
- Volume was 612.50K shares, 0.7x its 50-day average of 920.52K.
- Price is -12.7% vs its 50-day average ($3.33) and -1.1% vs its 200-day average ($2.94).
- 52-week range $1.62–$5.05; today's close sits at 37% of that range, 42.5% below the 52-week high.
NRXP latest news & SEC filings
Every SEC filing by or about NRXP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.10M (prior year $0)
- Net income: -$16.52M (prior year -$17.58M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.44 (prior year -$0.98) (loss narrowed vs Jun 30, 2025)
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade NRXP
- Last results release: Aug 17, 2026 (8-K Item 2.02). Previous ones: Aug 18, 2025, May 21, 2025, Mar 21, 2025. Based on that rhythm, the next report is likely around Nov 16, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.35% (largest 5.3%).
- Liquidity: about 654.03K shares (≈$1.70M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.60 vs a range of $1.62–$5.05 (29% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 16, 2026; 8-K Oct 5, 2026; 8-K Sep 16, 2026.
- Share count: 43.30M shares outstanding (Aug 14, 2026), +119.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NRXP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.70 | 2.76 | 2.57 | 2.60 | 1.21M |
| Oct 15, 2026 | 2.53 | 2.77 | 2.48 | 2.71 | 1.18M |
| Oct 14, 2026 | 2.64 | 2.70 | 2.56 | 2.59 | 695.80K |
| Oct 13, 2026 | 2.85 | 2.85 | 2.67 | 2.70 | 552.50K |
| Oct 12, 2026 | 2.85 | 2.93 | 2.82 | 2.85 | 479.10K |
| Oct 9, 2026 | 2.89 | 2.89 | 2.82 | 2.85 | 289.30K |
| Oct 8, 2026 | 2.88 | 2.89 | 2.81 | 2.89 | 645.60K |
| Oct 7, 2026 | 2.88 | 2.93 | 2.87 | 2.90 | 404.70K |
| Oct 6, 2026 | 2.89 | 2.97 | 2.83 | 2.94 | 418.10K |
| Oct 5, 2026 | 2.91 | 2.93 | 2.79 | 2.87 | 675.20K |
| Oct 2, 2026 | 2.91 | 2.94 | 2.82 | 2.90 | 612.50K |
| Oct 1, 2026 | 2.94 | 3.00 | 2.83 | 2.85 | 618.80K |
| Sep 30, 2026 | 3.04 | 3.06 | 2.91 | 2.92 | 1.17M |
| Sep 29, 2026 | 2.92 | 2.97 | 2.87 | 2.92 | 508.20K |
| Sep 28, 2026 | 2.95 | 3.01 | 2.87 | 2.87 | 732.50K |
| Sep 25, 2026 | 3.07 | 3.09 | 2.92 | 2.99 | 786.60K |
| Sep 24, 2026 | 3.15 | 3.15 | 3.03 | 3.03 | 678.20K |
| Sep 23, 2026 | 3.29 | 3.35 | 3.12 | 3.16 | 552.20K |
| Sep 22, 2026 | 3.30 | 3.33 | 3.21 | 3.32 | 493.90K |
| Sep 21, 2026 | 3.37 | 3.39 | 3.29 | 3.29 | 379.90K |
About NRX Pharmaceuticals
NRX Pharmaceuticals (NRXP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WILMINGTON, DE. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1719406.
NRXP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Joseph Michael Casper | Chief Operating Officer | Feb 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NRXP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.23M | $-28.62M | — | $-14.11M |
| Dec 31, 2024 | $0 | $-25.13M | — | $-10.64M |
| Dec 31, 2023 | — | $-30.15M | — | $-21.66M |
| Dec 31, 2022 | — | $-39.75M | -0.60 | $-39.76M |
| Dec 31, 2021 | — | $-93.06M | -1.98 | $-37.70M |
Latest balance sheet: total assets $34.16M, total liabilities $34.33M, cash $26.69M (as of Jun 30, 2026).
NRXP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 17, 2026 | 8-K Item 2.02 (results) | $3.43 |
| Aug 18, 2025 | 8-K Item 2.02 (results) | $2.76 |
| May 21, 2025 | 8-K Item 2.02 (results) | $2.63 |
| Mar 21, 2025 | 8-K Item 2.02 (results) | $2.08 |
| Nov 15, 2024 | 8-K Item 2.02 (results) | $1.19 |
| Aug 15, 2024 | 8-K Item 2.02 (results) | — |
| May 16, 2024 | 8-K Item 2.02 (results) | — |
| Apr 2, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
| Mar 31, 2023 | 8-K Item 2.02 (results) | — |
| Nov 14, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NRXP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.